Michael Eisen | |
---|---|
Born | Michael Bruce Eisen April 13, 1967 |
Nationality | American |
Alma mater | Harvard University (AB, PhD) |
Known for | Public Library of Science (PLOS) |
Awards | Benjamin Franklin Award (Bioinformatics) (2002) |
Scientific career | |
Fields | |
Institutions | University of California, Berkeley |
Thesis | Structural Studies of Influenza A Virus Proteins (1996) |
Doctoral advisor | Don Craig Wiley [ citation needed ] |
Website | michaeleisen |
Michael Bruce Eisen (born April 13, 1967) is an American computational biologist and the former [2] editor-in-chief of the journal eLife. [3] He is a professor of genetics, genomics and development at University of California, Berkeley. [4] [5] [6] [7] [8] He is a leading advocate of open access scientific publishing and is co-founder of Public Library of Science (PLOS). In 2018, Eisen announced his candidacy U.S. Senate from California as an Independent, though he failed to qualify for the ballot. [9]
Born in Boston, Eisen and his brother Jonathan were raised in a family of scientists. Their grandfather was an x-ray crystallographer, their father, Howard Eisen a physician, and mother, Laura [10] a biochemist. They moved to Bethesda, Maryland when Eisen was four or five years old. The brothers spent summers in Long Island with their grandparents. Eisen states that he loved frogs and salamanders '"Even more than I have a frog fetish, I have a swamp fetish. I really like being in swamps."' He was also very interested in math and was captain of the high school math team. Eisen graduated from Walt Whitman High School in 1985. Intending to major in mathematics at Harvard University, he realized that there [he may encounter] other more brilliant math students, it was a Good Will Hunting moment and he decided that he did not want to major in mathematics, '"You don't want to be Salieri to Mozart."' During his years at Harvard, Eisen worked on "unlocking the three-dimensional structures of proteins." He was shown a DNA microarray which taught him a '"new way of doing biology"'. [11]
Eisen completed his PhD at Harvard University in biophysics and a B.S. (also from Harvard) in Math. [12] He was under the supervision of Don Craig Wiley [13] while studying Influenza A virus Proteins. [14]
There are things that are really really difficult, those are the kinds of problems you do want to work on. It's not that easy to tell the difference between impossible problems and a problem that is really really difficult. But learning to do so is critically important. - Things I learned from working with Pat Brown (Patrick O. Brown) - 2015 [13]
After earning his doctorate, Eisen was a Postdoctoral Fellow at Stanford University in the lab of David Botstein, where he most notably developed a method for interpreting gene expression data from microarrays. The seminal research publication that Eisen authored about this project has been cited over 16,000 times. [15]
When Eisen lived in Tennessee he worked as a play-by-play announcer for a minor league baseball team, [12] the Columbia Mules. He is a self-proclaimed Red Sox fanatic. [11] He and computational biologist James Fraser recorded a video for iBiology about the role baseball statistics influenced their research. Their argument is that sequencing DNA is similar to scoring a baseball game, and that many computational biologists learned to think about science computations from an obsessive interest in baseball stats. The exercise of comparing a specific player's stats to a database of other similar players allows a baseball fan to predict future performance. This same system works with proteins and predicting functions. As tools are developed that break down and track all stats concerning baseball players, so will technology improve with genetics. With both baseball and genetics, tools are being developed that refine the models. [16] In a lecture in 2015, Eisen stated that he received a computer from his grandfather for his twelfth birthday and spent the next five years teaching himself how to program so that he could keep track of baseball stats. [13]
His academic research focuses on the evolution of gene regulation. [17] [18] [19] [20] Despite this focus, Eisen's work has historically spanned very diverse disciplines. For example, his 5 most cited papers cover a broad range of topics including methods for hierarchical clustering, [17] applications to human breast cancers (with David Botstein and Charles Perou), [6] and discovery of tumor subtypes in diffuse large B cell lymphoma (with Ash Alizadeh and Louis Staudt). [18] His more recent research work has been on fruit flies and Drosophila [21] and how they "develop from a tiny single-celled egg to a mature adult. He says they hold insights into what goes wrong in people as they age." [12] He receives funding from the Howard Hughes Medical Institute for his research. [21]
Eisen announced through Twitter on January 25 his intent to run for U.S. Senate from California in 2018 for Democratic Senator Dianne Feinstein's seat, registering the Twitter handle SenatorPhD. [22] His campaign slogan was "Liberty, Equality, Reality". Eisen's reasons for running for Congress included his perception that the Trump administration was unresponsive to climate change and other science-related issues. Another reason Eisen decided to run was his experience watching Cabinet appointees being interviewed by the Senate about climate change. He thought '“It would be really nice to have scientists ask the questions of the Cabinet appointees, because the senators don’t seem to understand the issue and aren’t asking the right questions.”' [12] He feels that if science is to be on the forefront of policy making, '"scientists need to run for office."' He felt that 2018's California jungle primaries afforded him a better chance at making the final two for the general election, but he did not make the final two (which were Dianne Feinstein and Kevin de León). [12]
For a really long time, scientists have watched political processes erode — and have watched politicians openly deride science, dismissing the role that science plays in our everyday life. Scientists have been sitting here hoping that someone would come along and defend those principals. Politics, in my mind, should function similar to science. We should try to figure out what’s going on in the world and then debate the best way to do it, to make the world better. The best tools we have to characterize reality are the observational tools that science uses all the time. Too much of politics has rejected that basic principle that scientists live and breathe all the time. [12]
Eisen dropped out of the race when he failed to qualify for the June 2018 primary ballot. [23]
In 2019, Eisen was named the second editor-in-chief of the open-access scientific journal eLife.
In 2020, in response to a Twitter question, Eisen joked that the roundworm C. elegans was the most over-hyped animal because "they wiggle forward. They wiggle backwards. And occasionally they fuck themselves. That’s it". Some researchers were not amused by the joke, and the eLife board asked Eisen to watch his language on Twitter. [24] [25] Also in 2020, Eisen was involved in the story surrounding the death from SARS-CoV-2 of an anonymous queer Hopi female professor with whom he had interacted on Twitter. The account turned out to be a hoax created and run by neuroscientist BethAnn McLaughlin, who founded MeTooSTEM. Eisen was one of three people to attend a Zoom memorial for the fictional individual. [26]
In 2023, under his leadership, the journal moved away from the traditional "review, then publish" model, instead requiring authors to submit preprints and then publishing journal editors' reviews alongside manuscripts, meaning that the journal neither accepted nor rejected submissions. [27] Eisen said that the move was intended to reduce the prominence of the publisher, and instead focus attention on authors and their work. This move provoked both enthusiastic praise from some, including some eLife editors, and a strong backlash from others inside the organization, including some senior editors and editors. A news article in the journal Nature described the “Strife at eLife”. At least one of five deputy editors resigned. In a private letter to Eisen in January 2023, 30 editors threatened to resign once the changes were fully implemented. In March 2023, 29 eLife editors, including founding editor-in-chief and Nobel Prize winner Randy Schekman, urged that Eisen should be replaced immediately in a letter to the executive editor of the journal’s publisher. Eisen dismissed this in an interview as “powerful scientists not wanting to change a system that has benefited them”. Eisen tweeted on March 12, 2023, that academics were "lobbying hard to get me fired", a post that was subsequently deleted. [28] He later described his relationship with the board as “somewhat testy” and that some “had it in for me”. [25]
On October 13, 2023, soon after Hamas attacked Israel, Eisen tweeted a story from by the satirical website The Onion with the headline: "Dying Gazans Criticized For Not Using Last Words To Condemn Hamas." Eisen said "The Onion speaks with more courage, insight and moral clarity than the leaders of every academic institution put together. I wish there were a @TheOnion university". [29] The post prompted some criticism, including from Israeli researchers who asked colleagues to avoid publishing in eLife as long as he was editor. The chair of eLife’s board asked Eisen to delete his Twitter post, but he refused to do so "because that would be capitulating to what I thought was a really misdirected effort to silence any expression of support of Palestinians". On October 23, 2023, Eisen was fired by eLife. In response to the firing, at least five of eLife's editors resigned and other scientists said they would stop participating in eLife events in solidarity with Eisen. A petition letter was organised to protest against Eisen’s firing. The petition, which was signed by over 2,000 scientists, academics and researchers, said eLife's action is having a "chilling effect" on freedom of expression in academia. [30]
eLife released a statement saying "Mike has been given clear feedback from the board that his approach to leadership, communication and social media has at key times been detrimental to the cohesion of the community we are trying to build and hence to eLife’s mission. It is against this background that a further incidence of this behaviour has contributed to the board’s decision". [29] Eisen's response was "They were referring to that fucking worm thing. I’m not even kidding!". [25] An eLife spokesperson clarified in an email to The Hindu, saying “We value and respect everyone’s right to freedom of speech including political expression and the legal right to protest. Particularly for those in leadership positions, exercising that right comes with responsibilities: an expectation to show good judgement and a duty of care to the communities they serve. We don’t believe those qualities have been demonstrated.” [31]
In eLife’s 2023 annual report, the Chair of the Board of Directors said: “In October, we parted ways with our Editor-in-Chief, Michael Eisen, and want to acknowledge the extraordinary vision and leadership he provided to eLife, which is allowing us to build on his legacy as we grow our publishing model.” [32]
On November 10, 2023, in response to a tweet saying “How to make faculty meeting more exciting? Wrong answers only.”, Eisen tweeted “Sit me next to Randy Schekman.”, indicating an ongoing personal conflict with the preceding editor-in-chief. [33]
Throughout his career he has been an advocate for "open science", which is the free release of the material and intellectual product of scientific research. He is a leading advocate of open access scientific publishing [34] [35] [36] and is co-founder of Public Library of Science (PLOS) and serves on the PLOS board, the Academic Steering & Advocacy Committee of Open Library of Humanities, [37] and is an adviser to Science Commons.
In 2012 Eisen began protesting against the Research Works Act as part of his appeal to promote open access to information. [38]
In 2002, Eisen was awarded the inaugural Benjamin Franklin Award in bioinformatics, for his work on PLOS and the open-access availability of his microarray cluster analysis software. [39]
PLOS is a nonprofit publisher of open-access journals in science, technology, and medicine and other scientific literature, under an open-content license. It was founded in 2000 and launched its first journal, PLOS Biology, in October 2003.
Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.
The transcriptome is the set of all RNA transcripts, including coding and non-coding, in an individual or a population of cells. The term can also sometimes be used to refer to all RNAs, or just mRNA, depending on the particular experiment. The term transcriptome is a portmanteau of the words transcript and genome; it is associated with the process of transcript production during the biological process of transcription.
Michael Ashburner was an English biologist and Professor in the Department of Genetics at University of Cambridge. He also served as joint-head and co-founder of the European Bioinformatics Institute (EBI) of the European Molecular Biology Laboratory (EMBL) and a Fellow of Churchill College, Cambridge.
Bruce Michael Alberts is an American biochemist and the Emeritus Chancellor’s Leadership Chair in Biochemistry and Biophysics for Science and Education at the University of California, San Francisco. He has done important work studying the protein complexes which enable chromosome replication when living cells divide. He is known as an original author of the "canonical, influential, and best-selling scientific textbook" Molecular Biology of the Cell, as an Editor-in-Chief of Science magazine. He was awarded the National Medal of Science for "intellectual leadership and experimental innovation in the field of DNA replication, and for unparalleled dedication to improving science education and promoting science-based public policy" in 2014.
Joseph Lyman DeRisi is an American biochemist, specializing in molecular biology, parasitology, genomics, virology, and computational biology.
Patrick O'Reilly Brown is an American scientist and businessman who is the founder of Impossible Foods Inc. and professor emeritus in the department of biochemistry at Stanford University. Brown is co-founder of the Public Library of Science, inventor of the DNA microarray, and a former investigator at Howard Hughes Medical Institute.
David Botstein is an American biologist who is the chief scientific officer of Calico. He was the director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University from 2003 to 2013, where he remains an Anthony B. Evnin Professor of Genomics.
ChIP-on-chip is a technology that combines chromatin immunoprecipitation ('ChIP') with DNA microarray ("chip"). Like regular ChIP, ChIP-on-chip is used to investigate interactions between proteins and DNA in vivo. Specifically, it allows the identification of the cistrome, the sum of binding sites, for DNA-binding proteins on a genome-wide basis. Whole-genome analysis can be performed to determine the locations of binding sites for almost any protein of interest. As the name of the technique suggests, such proteins are generally those operating in the context of chromatin. The most prominent representatives of this class are transcription factors, replication-related proteins, like origin recognition complex protein (ORC), histones, their variants, and histone modifications.
Terence Paul "Terry" Speed, FAA FRS is an Australian statistician. A senior principal research scientist at the Walter and Eliza Hall Institute of Medical Research, he is known for his contributions to the analysis of variance and bioinformatics, and in particular to the analysis of microarray data.
Takashi Gojobori is a Japanese molecular biologist, Vice-Director of the National Institute of Genetics (NIG) and the DNA Data Bank of Japan (DDBJ) at NIG, in Mishima, Japan. Gojobori is a Distinguished Professor at King Abdullah University of Science and Technology (KAUST) in Thuwal, Saudi Arabia. He is a Professor of Bioscience and Acting Director at the Computational Bioscience Research Center at KAUST.
Ira Herskowitz was an American phage and yeast geneticist who studied genetic regulatory circuits and mechanisms. He was particularly noted for his work on mating type switching and cellular differentiation, largely using Saccharomyces cerevisiae as a model organism.
Jonathan Andrew Eisen is an American evolutionary biologist, currently working at University of California, Davis. His academic research is in the fields of evolutionary biology, genomics and microbiology and he is the academic editor-in-chief of the open access journal PLOS Biology.
Olga G. Troyanskaya is an American scientist. She is Professor in the Department of Computer Science and the Lewis-Sigler Institute for Integrative Genomics at Princeton University and the Deputy Director for Genomics at the Flatiron Institute's Center for Computational Biology in New York City. She studies protein function and interactions in biological pathways by analyzing genomic data using computational tools.
Eran Segal is a computational biologist professor at the Weizmann Institute of Science. He works on developing quantitative models for all levels of gene regulation, including transcription, chromatin, and translation. Segal also works as an epidemiologist.
Ronald Wayne "Ron" Davis is professor of biochemistry and genetics, and director of the Stanford Genome Technology Center at Stanford University. Davis is a researcher in biotechnology and molecular genetics, particularly active in human and yeast genomics and the development of new technologies in genomics, with over 64 biotechnology patents. In 2013, it was said of Davis that "A substantial number of the major genetic advances of the past 20 years can be traced back to Davis in some way." Since his son fell severely ill with myalgic encephalomyelitis/chronic fatigue syndrome Davis has focused his research efforts into the illness.
eLife is a not-for-profit, peer-reviewed, open access, science publisher for the biomedical and life sciences. It was established at the end of 2012 by the Howard Hughes Medical Institute, Max Planck Society, and Wellcome Trust, following a workshop held in 2010 at the Janelia Farm Research Campus. Together, these organizations provided the initial funding to support the business and publishing operations. In 2016, the organizations committed US$26 million to continue publication of the journal.
Biological dark matter is an informal term for unclassified or poorly understood genetic material. This genetic material may refer to genetic material produced by unclassified microorganisms. By extension, biological dark matter may also refer to the un-isolated microorganisms whose existence can only be inferred from the genetic material that they produce. Some of the genetic material may not fall under the three existing domains of life: Bacteria, Archaea and Eukaryota; thus, it has been suggested that a possible fourth domain of life may yet be discovered, although other explanations are also probable. Alternatively, the genetic material may refer to non-coding DNA and non-coding RNA produced by known organisms.
Transcriptomics technologies are the techniques used to study an organism's transcriptome, the sum of all of its RNA transcripts. The information content of an organism is recorded in the DNA of its genome and expressed through transcription. Here, mRNA serves as a transient intermediary molecule in the information network, whilst non-coding RNAs perform additional diverse functions. A transcriptome captures a snapshot in time of the total transcripts present in a cell. Transcriptomics technologies provide a broad account of which cellular processes are active and which are dormant. A major challenge in molecular biology is to understand how a single genome gives rise to a variety of cells. Another is how gene expression is regulated.
Anne E. Carpenter is an American scientist in the field of image analysis for cell biology and artificial intelligence for drug discovery. She is the co-creator of CellProfiler, open-source software for high-throughput biological image analysis, and a co-inventor of the Cell Painting assay, a method for image-based profiling. She is an Institute Scientist and Senior Director of the Imaging Platform at the Broad Institute.